+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contrast Media Injectors Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • June 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855082
The global contrast media injectors market value was USD 1.5 billion in 2022, driven by the increasing demand for advanced imaging techniques across the globe. The market size is anticipated to grow at a CAGR of 7.2% during the forecast period of 2023-2031 to achieve a value of USD 2.8 billion by 2031.

Contrast Media Injectors: Introduction

Contrast media injectors, also known as contrast injectors or power injectors, are medical devices used to deliver contrast agents into the patient's bloodstream during medical imaging procedures such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and angiography. Contrast media are substances that enhance the visibility of blood vessels, organs, or tissues in medical images, allowing for better visualization and diagnosis of various conditions.

The use of contrast media injectors offers several advantages in medical imaging. They ensure precise and controlled delivery of contrast agents at the required rate and volume, resulting in improved image quality and diagnostic accuracy. These devices are equipped with programmable settings and advanced features that allow healthcare professionals to tailor the injection parameters to the specific needs of each patient, ensuring safety and optimal imaging results.

Key Trends in the Global Contrast Media Injectors Market

Some key trends in the market for contrast media injectors include:

  • Technological advancements: The market is witnessing continuous technological advancements in contrast media injectors. This includes the development of advanced injector systems with features such as automated control, dose monitoring, and integration with imaging systems. Manufacturers are also focusing on improving the user interface and ergonomics of the injectors to enhance usability and workflow efficiency
  • Integration with imaging systems: There is a growing trend towards the integration of contrast media injectors with imaging systems. This allows for seamless communication and synchronization between the injector and the imaging device, resulting in improved efficiency and accuracy of contrast administration
  • Safety and patient-centric features: Safety features are a significant focus in the market, with manufacturers incorporating advanced safety features in contrast media injectors. These may include pressure sensors to monitor injection pressures, automated waste management systems, and patient monitoring capabilities. The aim is to minimize the risk of adverse events and enhance patient safety during contrast injections
  • Increased automation and connectivity: Automation is a key trend in the market, with manufacturers developing injectors that offer automated injection protocols, including pre-set parameters based on patient characteristics and imaging requirements. Additionally, there is a growing emphasis on connectivity, with injectors integrating with electronic health record systems and radiology information systems to streamline data management and enhance connectivity across healthcare settings
  • Growing demand for portable and mobile injectors: The market is witnessing an increasing demand for portable and mobile contrast media injectors. These devices offer flexibility and convenience in various clinical settings, including emergency rooms, intensive care units, and ambulatory care centers. Portable injectors allow for on-the-go imaging procedures and facilitate point-of-care imaging in remote locations

Global Contrast Media Injectors Market Segmentations

Market Breakup by Product Type

Injector Systems

  • CT Injector Systems
  • MRI Injector Systems
  • Cardiovascular/Angiography Injector Systems

Consumables

  • Tubing
  • Syringe
  • Others

Market Breakup by Type

  • Single Head Injectors
  • Dual-Head Injectors
  • Syringe less Injectors

Market Breakup by Applications

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
  • Others

Market Breakup by End User

  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgery Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Contrast Media Injectors Market Scenario

Contrast media injectors play a crucial role in medical imaging procedures by delivering contrast agents to enhance the visibility of specific organs, tissues, or blood vessels. These injectors provide precise and controlled administration of contrast media, ensuring accurate and reliable imaging results. The market for contrast media injectors is driven by the growing demand for advanced imaging techniques, the increasing prevalence of chronic diseases requiring diagnostic imaging, and the need for improved patient safety and workflow efficiency.

The market offers a wide range of contrast media injectors with varying features and capabilities. These injectors are designed to meet the diverse needs of healthcare facilities, including hospitals, diagnostic centers, and ambulatory care settings. They are available in different configurations, such as single-head or multi-head injectors, and offer various functionalities such as pressure monitoring, automated protocols, and connectivity with imaging systems.

Overall, the market for contrast media injectors is driven by technological advancements, increasing demand for advanced imaging techniques, and the need for improved patient safety and workflow efficiency. As medical imaging continues to play a vital role in diagnosis and treatment, the demand for high-quality and reliable contrast media injectors is expected to grow.

Global Contrast Media Injectors Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • General Electric
  • Vivid Imaging Solutions
  • Hilin Life Products, Inc
  • Jodas Expoim Pvt. Ltd
  • Lantheus
  • Magnus Health
  • TAEJOON PHARM
  • Spago Nanomedical AB
  • Guerbet
  • Bracco
  • Bayer AG
  • Medtron AG
  • NemotoKyorindo Co., Ltd
  • ulrich GmbH & Co. KG
  • Sino Medical-Device Technology Co
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contrast Media Injectors Market Overview
3.1 Global Contrast Media Injectors Market Historical Value (2016-2022)
3.2 Global Contrast Media Injectors Market Forecast Value (2023-2031)
4 Global Contrast Media Injectors Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Contrast Media Injectors Market Segmentation
5.1 Global Contrast Media Injectors Market by Product Type
5.1.1 Market Overview
5.1.2 Injector Systems
5.1.2.1 CT Injector Systems
5.1.2.2 MRI Injector Systems
5.1.2.3 Cardiovascular/Angiography Injector Systems
5.1.3 Consumables
5.1.3.1 Tubing
5.1.3.2 Syringe
5.1.3.3 Others
5.2 Global Contrast Media Injectors Market by Type
5.2.1 Market Overview
5.2.2 Single Head Injectors
5.2.3 Dual-Head Injectors
5.2.4 Syringe less Injectors
5.3 Global Contrast Media Injectors Market by Applications
5.3.1 Market Overview
5.3.2 Radiology
5.3.3 Interventional Cardiology
5.3.4 Interventional Radiology
5.3.5 Others
5.4 Global Contrast Media Injectors Market by End User
5.4.1 Market Overview
5.4.2 Hospitals
5.4.3 Diagnostics Centres
5.4.4 Ambulatory Surgery Centres
5.4.5 Others
5.5 Global Contrast Media Injectors Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Contrast Media Injectors Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Contrast Media Injectors Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Contrast Media Injectors Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Contrast Media Injectors Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Contrast Media Injectors Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 General Electric
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Vivid Imaging Solutions
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Hilin Life Products, Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Jodas Expoim Pvt. Ltd.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Lantheus
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 Magnus Health
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 TAEJOON PHARM
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 Spago Nanomedical AB
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 Guerbet
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 Bracco
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
16.11 Bayer AG
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisition
16.11.5 Certifications
16.12 Medtron AG
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisition
16.12.5 Certifications
16.13 NemotoKyorindo Co., Ltd.
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisition
16.13.5 Certifications
16.14 ulrich GmbH & Co. KG
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisition
16.14.5 Certifications
16.15 Sino Medical-Device Technology Co.
16.15.1 Financial Analysis
16.15.2 Product Portfolio
16.15.3 Demographic Reach and Achievements
16.15.4 Mergers and Acquisition
16.15.5 Certifications
17 Global Contrast Media Injectors Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • General Electric
  • Vivid Imaging Solutions
  • Hilin Life Products, Inc.
  • Jodas Expoim Pvt. Ltd.
  • Lantheus
  • Magnus Health
  • TAEJOON PHARM
  • Spago Nanomedical AB
  • Guerbet
  • Bracco
  • Bayer AG
  • Medtron AG
  • NemotoKyorindo Co., Ltd.
  • ulrich GmbH & Co. KG
  • Sino Medical-Device Technology Co.

Methodology

Loading
LOADING...

Table Information